The TTN is recognized as a significant contributor to cardiovascular disease, and 15 to 25% of individuals diagnosed with DCM have been found to harbor a heterozygous TTN-truncating variant as the causative genetic factor [52]. This evidence concerns the gene TTN and cardiovascular disorder.